HOWL · Werewolf Therapeutics Inc
United States · RS rating 82 · As of 2026-10-14
| Price | 0.98 USD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 82 / 69 / 98 / 17 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 31 / 47 / 50 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +44.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +44.6% |
| Market cap (USD) | $41.8M |